Efficacy estimand This estimand is used to assess the average treatment effect of bimagrumab, semaglutide or bimagrumab plus semaglutide for all randomized participants at weeks 48 and 72 had they received at least one dose of study treatment, adhered to protocol-defined treatment and did not discontinue treatment prematurely
For studies focused on lean muscle accretion, fat metabolism, or cellular repair, this clean signaling is invaluable
You know precision is everything in research, and the very first stepreconstitutionsets the stage for the validity of your entire project
Weight Management Goals For individuals using GLP-1 agonists to aid in weight loss, alcohol can be counterproductive
10.1016/0922-4106(90)90124-G 136
[DOI] [PubMed] [Google Scholar] 33.McMenamin M.E., Fletcher C.D